Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation (VREX) delivers critical x-ray components for medical diagnostics and industrial inspection systems worldwide. This page provides investors and industry professionals with a comprehensive resource for tracking the company's latest press releases, financial announcements, and strategic developments.
Find timely updates on quarterly earnings, new product launches, and partnerships that shape Varex's leadership in imaging technology. Our curated collection includes regulatory filings, manufacturing innovations, and market expansion updates across both medical and industrial segments.
Bookmark this page to monitor how Varex's advancements in digital detectors, x-ray tubes, and quality engineering impact global healthcare and industrial inspection markets. Check regularly for objective reporting on developments affecting the medical imaging supply chain and non-destructive testing solutions.
Varex (Nasdaq: VREX) reported Q4 FY2025 and full-year results on November 18, 2025. Q4 revenue was $229M (+11% YoY); Medical $152M (+5% YoY) and Industrial $77M (+25% YoY). Q4 non-GAAP gross margin was 34% and non-GAAP EPS was $0.37 (vs $0.19 a year ago). FY2025 revenue was $845M (+4% YoY); non-GAAP EBITDA rose 37% to $122M and non-GAAP EPS was $0.90 (+73%). Cash and equivalents were $155M at year-end after paying principal on convertible notes on June 2, 2025. Q1 FY2026 guidance: revenue $200–$215M, non-GAAP EPS $0.05–$0.25. Conference call held Nov 18, 2025.
Varex Imaging (Nasdaq: VREX) will report unaudited financial results for the fourth quarter and fiscal year 2025 after market close on Tuesday, November 18, 2025. A conference call and live webcast will follow at 3:00 PM Mountain Time that day.
Investors can join the live webcast at www.vareximaging.com/investor-relations/ or by phone at 877-524-8416 (U.S.) and 412-902-1028 (non-U.S.). The call webcast will be archived and a replay will be available from November 18 through December 2, 2025 at 877-660-6853 (U.S.) or 201-612-7415 (non-U.S.) using access code 13756256.
Varex designs and manufactures X-ray imaging components and systems and is headquartered in Salt Lake City, employing about 2,300 people globally.
Varex Imaging Corporation (Nasdaq: VREX) announced its upcoming participation in the Sidoti Small Cap Virtual Conference. The company's management team will deliver a presentation on Wednesday, September 17, 2025 at 3:15 PM ET. Investors can access the webcast through the provided link or via Varex's corporate website at vareximaging.com/news.
Varex Imaging (NASDAQ: VREX) reported Q3 FY2025 financial results with revenues of $203 million, exceeding guidance but down 3% year-over-year. The company's Medical segment revenue decreased 4% to $142 million, while the Industrial segment revenue grew 1% to $61 million.
Non-GAAP gross margin improved to 34% from 32% in Q3 FY2024, with non-GAAP EPS increasing to $0.18 from $0.14. Operating cash flow was $8 million, with cash and equivalents at $153 million after paying down Convertible Notes. For Q4 FY2025, Varex expects revenues between $210-230 million and non-GAAP EPS of $0.10-0.30.
Varex Imaging Corporation (Nasdaq: VREX), a leading manufacturer of X-ray imaging components, has scheduled its third quarter fiscal year 2025 earnings release and conference call. The company will announce its unaudited financial results on Thursday, August 7, 2025, after market close, followed by a conference call at 3:00 PM Mountain Time.
Investors can access the conference call via U.S. toll-free number (877-524-8416) or international number (412-902-1028). The webcast will be available on the company's investor relations website, with a replay accessible through August 21st using access code 13754994.
Varex Imaging (Nasdaq: VREX) has secured new orders worth $17 million for its high-energy non-intrusive cargo and vehicle inspection systems from international customers. The systems will be deployed at strategic sea and land ports for security purposes.
CEO Sunny Sanyal highlighted that the company's Cargo Systems business has received orders totaling over $55 million year-to-date, demonstrating Varex's strong position in high-energy Linear Accelerator based imaging technology and its integration capabilities.
Varex Imaging Corporation (VREX) has announced its participation in the upcoming Jefferies Global Healthcare Conference in New York. The company's management team is scheduled to deliver a presentation on Wednesday, June 4, 2025, at 8:10 AM ET. Interested parties can access the webcast through a provided link or via Varex's official website at www.vareximaging.com/news.
Varex Imaging Corporation (VREX) has secured orders worth $25 million USD for its high-energy non-intrusive cargo and vehicle inspection systems from an international customer. The systems will be deployed at strategic sea and land ports for security purposes. CEO Sunny Sanyal highlighted the company's leadership in high-energy Linear Accelerator based imaging technology, emphasizing how their reputation for quality and excellence has helped secure new business in Cargo Systems.
Varex Imaging (VREX) has announced it will release its unaudited financial results for the second quarter of fiscal year 2025 after market close on Thursday, May 8, 2025. The company will host a conference call at 3:00 pm Mountain Time on the same day.
Investors can participate through multiple channels: via webcast on the company's investor relations website, by calling 877-524-8416 (U.S.) or 412-902-1028 (international). A replay will be available from May 8th through May 22nd.
Varex is a leading manufacturer of X-ray imaging components and systems, with a 70+ year history in innovation. The company produces X-ray tubes, digital detectors, and imaging solutions for both medical and industrial applications, employing approximately 2,300 people across North America, Europe, and Asia.